一个更新的纳米药物交付的景观,以缓解结肠癌的缓解
Maria Shahzad1, Huma Hameed2, Ayesha Amjad3
1Faculty of Pharmaceutical Sciences, University of Central Punjab (UCP), Lahore, 54000, Pakistan.
Naunyn-Schmiedeberg's archives of pharmacology
|October 3, 2024
概括
纳米技术提供了先进的结肠直肠癌 (CRC) 治疗方法,通过使向药物输送成为可能. 纳米材料提高了药物的疗效,减少了副作用,在CRC治疗中显示出更好的患者结果的希望.
科学领域:
- 在瘤学瘤学.
- 纳米医学是一种纳米医学.
- 药物输送系统 药物输送系统
背景情况:
- 结肠直肠癌 (CRC) 仍然是全球癌症死亡的主要原因.
- 传统的CRC疗法面临着诸如系统性毒性,多药性耐药性和非特异性向等挑战.
- 复杂的CRC病理生理学需要先进的治疗策略.
研究的目的:
- 审查针对结直肠癌的基于纳米技术的药物输送系统的最新进展.
- 探索各种纳米材料及其在提高CRC治疗疗效方面的应用.
- 总结临床前和临床证据关于纳米医学在CRC治疗中的好处.
主要方法:
- 关于纳米技术在结直肠癌药物输送中的应用现有文献的综述.
- 分析各种纳米材料,包括脂质体,树脂体,体,外体和金纳米颗粒.
- 检查表明药物递送和治疗结果得到改善的临床前和临床研究.
主要成果:
- 像脂质体和黄金纳米颗粒这样的纳米材料提高了药物的溶解性,稳定性和针对CRC的向输送.
- 基于纳米技术的系统克服了传统疗法的局限性,提高了治疗效率.
- 临床前和临床研究表明,纳米配方在结肠特异性输送方面取得了显著的积极结果.
结论:
- 纳米技术为先进和个性化结直肠癌治疗提供了一个有前途的途径.
- 纳米配方通过改善药物输送和降低毒性来改善患者的治疗结果.
- 未来的研究应该专注于大规模的临床试验和优化纳米材料配方,以获得监管批准和广泛使用.
相关概念视频
01:16Drug Delivery: Overview
1.3K
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
1.3K
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
332
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
332
01:19Modified-Release Drug Delivery Systems: Overview
236
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
236
01:20Modified-Release Drug Delivery Systems: Influencing Factors
208
Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...
208
01:24Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160